Regeneron Reported Fourth-Quarter Net Income of $1.15B

TARRYTOWN, N.Y. —  Regeneron Pharmaceuticals Inc. (REGN) on Friday reported fourth-quarter net income of $1.15 billion.

On a per-share basis, the Tarrytown, New York-based company said it had net income of $10.24. Earnings, adjusted for one-time gains and costs, were $9.53 per share.

The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $8.32 per share.

The biopharmaceutical company posted revenue of $2.42 billion in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $2.39 billion.

For the year, the company reported profit of $3.51 billion, or $30.52 per share. Revenue was reported as $8.5 billion.

Regeneron shares have risen slightly more than 3% since the beginning of the year, while the Standard & Poor's 500 index has risen 3%. The stock has risen 40% in the last 12 months.


ASTORIA – Variety Boys & Girls Club of Queens was recently selected a winner in Round Three of New York State’s Buildings of Excellence Competition for the design and construction of a low-carbon (or net-zero) emitting multifamily building.

Top Stories


A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.


Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.